These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 25807036)
1. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036 [TBL] [Abstract][Full Text] [Related]
2. Role of IgA receptors in the pathogenesis of IgA nephropathy. Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664 [TBL] [Abstract][Full Text] [Related]
3. Food antigens and Transglutaminase 2 in IgA nephropathy: Molecular links between gut and kidney. Abbad L; Monteiro RC; Berthelot L Mol Immunol; 2020 May; 121():1-6. PubMed ID: 32135400 [TBL] [Abstract][Full Text] [Related]
4. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. Berthelot L; Papista C; Maciel TT; Biarnes-Pelicot M; Tissandie E; Wang PH; Tamouza H; Jamin A; Bex-Coudrat J; Gestin A; Boumediene A; Arcos-Fajardo M; England P; Pillebout E; Walker F; Daugas E; Vrtosvnik F; Flamant M; Benhamou M; Cogné M; Moura IC; Monteiro RC J Exp Med; 2012 Apr; 209(4):793-806. PubMed ID: 22451718 [TBL] [Abstract][Full Text] [Related]
5. Gluten and IgA nephropathy: you are what you eat? Cheung CK; Barratt J Kidney Int; 2015 Aug; 88(2):215-8. PubMed ID: 26230197 [TBL] [Abstract][Full Text] [Related]
6. The Gut-Renal Connection in IgA Nephropathy. Coppo R Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022 [TBL] [Abstract][Full Text] [Related]
7. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544 [TBL] [Abstract][Full Text] [Related]
8. Murine Models of Human IgA Nephropathy. Suzuki H; Suzuki Y Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023 [TBL] [Abstract][Full Text] [Related]
9. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy. Lechner SM; Abbad L; Boedec E; Papista C; Le Stang MB; Moal C; Maillard J; Jamin A; Bex-Coudrat J; Wang Y; Li A; Martini PG; Monteiro RC; Berthelot L J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635 [TBL] [Abstract][Full Text] [Related]
10. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases. Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091 [TBL] [Abstract][Full Text] [Related]
11. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy. Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939 [TBL] [Abstract][Full Text] [Related]
12. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy. Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952 [TBL] [Abstract][Full Text] [Related]
13. Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics. Papista C; Gerakopoulos V; Kourelis A; Sounidaki M; Kontana A; Berthelot L; Moura IC; Monteiro RC; Yiangou M Lab Invest; 2012 Apr; 92(4):625-35. PubMed ID: 22330344 [TBL] [Abstract][Full Text] [Related]
15. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333 [TBL] [Abstract][Full Text] [Related]
16. Gluten sensitivity in patients with IgA nephropathy. Smerud HK; Fellström B; Hällgren R; Osagie S; Venge P; Kristjánsson G Nephrol Dial Transplant; 2009 Aug; 24(8):2476-81. PubMed ID: 19332868 [TBL] [Abstract][Full Text] [Related]
17. Pathogenic significance of IgA receptor interactions in IgA nephropathy. Monteiro RC; Moura IC; Launay P; Tsuge T; Haddad E; Benhamou M; Cooper MD; Arcos-Fajardo M Trends Mol Med; 2002 Oct; 8(10):464-8. PubMed ID: 12383768 [TBL] [Abstract][Full Text] [Related]
18. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814 [TBL] [Abstract][Full Text] [Related]
19. Deposition of IgA in primary IgA nephropathy: it takes at least four to tango. Daha MR; van Kooten C Nephrol Dial Transplant; 2013 Apr; 28(4):794-7. PubMed ID: 23234754 [TBL] [Abstract][Full Text] [Related]
20. Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History. Wu H; Wang X; Yang Z; Zhao Q; Wen Y; Li X; Zhang W; Gao R Dis Markers; 2020; 2020():8393075. PubMed ID: 32076466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]